Skip to Content

WPI 338 (Diclofenac sodium delayed release 50 mg)

Pill imprint WPI 338 has been identified as Diclofenac sodium delayed release 50 mg.

Diclofenac is used in the treatment of back pain; frozen shoulder; pain; osteoarthritis; rheumatoid arthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release
Imprint:
WPI 338
Strength:
50 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0338

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide